Access cutting-edge acanthamoeba keratitis treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access acanthamoeba keratitis specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acanthamoeba keratitis treatment provided free
The Parasitic Ulcer Treatment Trial (PUTT) is a multi-center, parallel-group, randomized clinical trial. The purpose of this study is to determine whether including topical corticosteroids in a regimen for acanthamoeba keratitis (AK) will improve vision. Patients presenting to all enrollment centers with evidence of acanthamoeba keratitis will be eligible for the trial if there is evidence of ocular inflammation after 4 weeks of anti-amoebic therapy. Those who agree to participate will be random
Sponsor: Jeremy Keenan, MD, MPH
Check if you qualify for this acanthamoeba keratitis clinical trial in Chicago, IL
If you're searching for acanthamoeba keratitis treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acanthamoeba keratitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.